Additional Information
Book Details
Abstract
Respiratory System, 2nd Edition provides a concise and highly visual approach to the basic sciences and clinical pathology of this body system. This volume in The Netter Collection of Medical Illustrations (the CIBA "Green Books") has been expanded and revised by Dr. David Kaminsky to cover important topics like pulmonary hypertension, COPD, asthma, drug-resistant TB, modern endoscopic and surgical techniques, and more. Classic Netter art, updated illustrations, and modern imaging make this timeless work essential to your library.
- Access rare illustrations in one convenient source from the only Netter work devoted specifically to the respiratory system.
- Get a complete overview of the respiratory system through multidisciplinary coverage from physiology and biochemistry to adult and pediatric medicine and surgery.
- Gain a quick understanding of complex topics from a concise text-atlas format that provides a context bridge between primary and specialized medicine.
- Grasp the nuances of the pathophysiology of today’s major respiratory conditions—including pulmonary hypertension, COPD, asthma, environmental lung disease, sleep disorders, infections of the immunocompromised, neonatal breathing disorders, and drug-resistant TB, and modern endoscopic and surgical techniques—through advances in molecular biology and radiologic imaging.
- Benefit from the expertise of the new editor, David Kaminsky, MD, who contributes significant experience in asthma and general pulmonary and critical care medicine, and his team of world class contributors.
- Clearly see the connection between basic and clinical sciences with an integrated overview of normal structure and function as it relates to pathologic conditions.
- Apply a visual approach—with the classic Netter art, updated illustrations, and modern imaging—to normal and abnormal body function and the clinical presentation of the patient.
- Tap into the perspectives of an international advisory board for content that reflects the current global consensus.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front cover | Cover | ||
| Title page | iii | ||
| Copyright page | iv | ||
| ABOUT THE SERIES | v | ||
| ABOUT THE EDITOR | vi | ||
| PREFACE | vii | ||
| ABOUT THE ARTIST FROM THE FIRST EDITION | viii | ||
| INTRODUCTION TO THE FIRST EDITION | ix | ||
| ADVISORY BOARD | x | ||
| CONTRIBUTORS | xi | ||
| Table of contents | xiii | ||
| SECTION 1: ANATOMY AND EMBRYOLOGY | 1 | ||
| RESPIRATORY SYSTEM | 3 | ||
| BONY THORAX | 4 | ||
| RIB CHARACTERISTICS AND COSTOVERTEBRAL ARTICULATIONS | 5 | ||
| ANTERIOR THORACIC WALL | 6 | ||
| MUSCLES OF THE UPPER EXTREMITY | 6 | ||
| MUSCLES OF THE ANTEROLATERAL ABDOMINAL WALL | 6 | ||
| INTRINSIC MUSCLES OF THE THORAX | 6 | ||
| NERVES OF THE ANTERIOR THORACIC WALL | 7 | ||
| ARTERIES OF THE ANTERIOR THORACIC WALL | 7 | ||
| VEINS OF THE ANTERIOR THORACIC WALL | 7 | ||
| LYMPHATIC DRAINAGE OF THE ANTERIOR THORACIC WALL | 8 | ||
| DORSAL ASPECT OF THE THORAX | 9 | ||
| INTERCOSTAL NERVES AND ARTERIES | 11 | ||
| DIAPHRAGM (VIEWED FROM ABOVE) | 12 | ||
| TOPOGRAPHY OF THE LUNGS (ANTERIOR VIEW) | 13 | ||
| TOPOGRAPHY OF THE LUNGS (POSTERIOR VIEW) | 14 | ||
| MEDIAL SURFACE OF THE LUNGS | 15 | ||
| MEDIAL SURFACE OF THE RIGHT LUNG | 15 | ||
| MEDIAL SURFACE OF THE LEFT LUNG | 15 | ||
| BRONCHOPULMONARY SEGMENTS | 16 | ||
| RIGHT LUNG | 16 | ||
| LEFT LUNG | 17 | ||
| RELATIONSHIPS OF THE TRACHEA AND MAIN BRONCHI | 18 | ||
| BRONCHIAL ARTERIES | 19 | ||
| MEDIASTINUM | 20 | ||
| RIGHT THORACIC CAVITY | 20 | ||
| LEFT THORACIC CAVITY | 21 | ||
| INNERVATION OF THE LUNGS AND TRACHEOBRONCHIAL TREE | 22 | ||
| AUTONOMIC AFFERENT FIBERS | 22 | ||
| PARASYMPATHETIC EFFERENT FIBERS | 22 | ||
| SYMPATHETIC EFFERENT FIBERS | 22 | ||
| STRUCTURE OF THE TRACHEA AND MAJOR BRONCHI | 23 | ||
| LOBES AND SEGMENTS | 23 | ||
| INTRAPULMONARY AIRWAYS | 24 | ||
| STRUCTURE OF BRONCHI AND BRONCHIOLES—LIGHT MICROSCOPY | 25 | ||
| BLOOD SUPPLY | 25 | ||
| VENOUS DRAINAGE | 25 | ||
| LYMPHATICS | 25 | ||
| NERVE SUPPLY | 25 | ||
| ULTRASTRUCTURE OF THE TRACHEAL, BRONCHIAL, AND BRONCHIOLAR EPITHELIUM | 26 | ||
| BRONCHIAL SUBMUCOSAL GLANDS | 27 | ||
| INTRAPULMONARY BLOOD CIRCULATION | 28 | ||
| ARTERIES | 28 | ||
| VEINS | 28 | ||
| PRECAPILLARY ANASTOMOSIS | 28 | ||
| FINE STRUCTURE OF ALVEOLAR CAPILLARY UNIT | 29 | ||
| ALVEOLAR CELLS AND SURFACE-ACTIVE LAYER | 29 | ||
| ENDOTHELIAL CELL STRUCTURE | 30 | ||
| LYMPHATIC DRAINAGE OF THE LUNGS AND PLEURA | 32 | ||
| PULMONARY IMMUNOLOGY: LYMPHOCYTES, MAST CELLS, EOSINOPHILS, AND NEUTROPHILS | 34 | ||
| DEVELOPMENT OF THE LOWER RESPIRATORY SYSTEM | 35 | ||
| PRIMITIVE RESPIRATORY TUBE | 35 | ||
| TRACHEA | 35 | ||
| BRONCHI | 36 | ||
| CARTILAGE, SMOOTH MUSCLE, AND CONNECTIVE TISSUE | 36 | ||
| PLEURAL CAVITIES | 37 | ||
| DIAPHRAGM | 38 | ||
| PLEURA AND MEDIASTINUM | 40 | ||
| TERMINAL RESPIRATORY TUBES | 40 | ||
| SURFACTANT | 42 | ||
| FIRST BREATH | 43 | ||
| PHYSIOLOGY OF THE PERINATAL PULMONARY CIRCULATION | 45 | ||
| SECTION 2: PHYSIOLOGY | 47 | ||
| PULMONARY MECHANICS AND GAS EXCHANGE | 49 | ||
| RESPIRATORY MUSCLES | 49 | ||
| LUNG VOLUMES AND SUBDIVISIONS | 50 | ||
| MEASURING LUNG VOLUMES | 50 | ||
| MECHANICS OF VENTILATORY APPARATUS | 51 | ||
| SURFACE TENSION | 53 | ||
| PULMONARY CIRCULATION | 59 | ||
| DIFFUSION | 61 | ||
| GAS EXCHANGE | 63 | ||
| ALVEOLAR HYPOVENTILATION | 65 | ||
| VENTILATION-PERFUSION RELATIONSHIPS | 65 | ||
| OXYGEN TRANSPORT | 67 | ||
| CARBON DIOXIDE TRANSPORT | 68 | ||
| ACID-BASE REGULATION | 69 | ||
| RESPONSE TO OXIDANT INJURY | 70 | ||
| INACTIVATION OF CIRCULATING VASOACTIVE SUBSTANCES | 71 | ||
| ACTIVATION OF CIRCULATING PRECURSORS OF VASOACTIVE SUBSTANCES | 72 | ||
| CONTROL AND DISORDERS OF RESPIRATION | 73 | ||
| CHEMICAL RECEPTORS | 73 | ||
| PONTINE CENTERS | 74 | ||
| NEUROCHEMICAL CONTROL OF EXERCISE HYPERPNEA | 75 | ||
| RESPONSES AND ADAPTATION TO HYPOXIA | 76 | ||
| COMMON DISORDERS OF RESPIRATORY CONTROL | 76 | ||
| HYPERVENTILATION | 77 | ||
| HYPOVENTILATION | 77 | ||
| UNSTABLE OR IRREGULAR VENTILATION | 78 | ||
| DRUGS THAT AFFECT VENTILATORY DRIVE | 78 | ||
| DISRUPTION OF NORMAL BREATHING CONTROL IN SELECTED DISEASES | 79 | ||
| SECTION 3: DIAGNOSTIC PROCEDURES | 81 | ||
| TESTS OF PULMONARY FUNCTION | 82 | ||
| RADIOLOGIC EXAMINATION OF THE LUNGS | 85 | ||
| ROUTINE EXAMINATION | 85 | ||
| COMPUTED TOMOGRAPHY | 86 | ||
| CONTRAST EXAMINATIONS | 87 | ||
| RADIONUCLIDE IMAGING | 90 | ||
| MAGNETIC RESONANCE IMAGING | 91 | ||
| SONOGRAPHY | 91 | ||
| INTERPRETATION OF RADIOGRAPHIC PATTERNS | 91 | ||
| EXHALED BREATH ANALYSIS | 101 | ||
| FLEXIBLE BRONCHOSCOPY | 102 | ||
| EQUIPMENT | 102 | ||
| BRONCHOSCOPIC VIEWS | 103 | ||
| NOMENCLATURE FOR PERIPHERAL BRONCHI | 104 | ||
| RIGID BRONCHOSCOPY | 105 | ||
| INSTRUMENTS | 105 | ||
| PROCEDURE | 105 | ||
| ENDOBRONCHIAL ULTRASONOGRAPHY | 106 | ||
| MEDIASTINOTOMY AND MEDIASTINOSCOPY | 107 | ||
| STAGING IN THE MANAGEMENT OF LUNG CARCINOMA | 107 | ||
| SURGICAL EVALUATION OF THE REGIONAL LYMPHATIC SYSTEM | 107 | ||
| SECTION 4: DISEASES AND PATHOLOGY | 109 | ||
| CONGENITAL DEFORMITIES OFTHE THORACIC CAGE | 111 | ||
| PECTUS EXCAVATUM | 111 | ||
| PECTUS CARINATUM | 111 | ||
| BIFID STERNUM | 111 | ||
| SKELETAL DISORDERS PRESENTING WITH NEONATAL RESPIRATORY DISTRESS | 111 | ||
| KYPHOSCOLIOSIS | 112 | ||
| CONGENITAL DIAPHRAGMATIC HERNIA | 114 | ||
| TRACHEOESOPHAGEAL FISTULAS AND TRACHEAL ANOMALIES | 115 | ||
| ANOMALIES AND STRICTURES OF THE TRACHEA | 115 | ||
| PULMONARY AGENESIS, APLASIA, AND HYPOPLASIA | 116 | ||
| CONGENITAL LUNG CYSTS | 117 | ||
| CONGENITAL CYSTIC ADENOMATOID MALFORMATION OF THE LUNG | 117 | ||
| CONGENITAL PULMONARY LYMPHANGIECTASIS | 117 | ||
| PULMONARY SEQUESTRATION | 118 | ||
| INTRALOBAR SEQUESTRATION | 118 | ||
| EXTRALOBAR SEQUESTRATION | 118 | ||
| CONGENITAL LOBAR EMPHYSEMA | 119 | ||
| CHRONIC COUGH | 120 | ||
| COMMON LARYNGEAL LESIONS | 121 | ||
| LARYNGEAL AND TRACHEAL STENOSIS | 122 | ||
| VOCAL CORD DYSFUNCTION | 123 | ||
| BRONCHIAL ASTHMA | 124 | ||
| CLINICAL FORMS OF BRONCHIAL ASTHMA | 124 | ||
| INDUCERS AND INCITERS OF ASTHMA | 124 | ||
| CLINICAL PRESENTATION | 126 | ||
| DIAGNOSIS OF ASTHMA | 127 | ||
| AIRWAY HYPERRESPONSIVENESS | 127 | ||
| INVESTIGATIONS THAT MAY BE CONSIDERED TO ESTABLISH A DIAGNOSIS | 128 | ||
| DIFFERENTIAL DIAGNOSIS | 129 | ||
| PHYSIOLOGIC ABNORMALITIES IN ASTHMA | 129 | ||
| PATHOGENESIS OF ASTHMA | 131 | ||
| IMMUNOLOGIC ABNORMALITIES | 132 | ||
| PATHOLOGIC CHANGES IN ASTHMA | 133 | ||
| LONG-TERM MANAGEMENT OF ASTHMA | 134 | ||
| TREATMENT OF SEVERE ASTHMA EXACERBATIONS | 136 | ||
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 138 | ||
| SUBTYPES | 138 | ||
| EPIDEMIOLOGY | 139 | ||
| RISK FACTORS | 139 | ||
| NATURAL HISTORY | 139 | ||
| CLINICAL FEATURES | 140 | ||
| PREDOMINANCE OF EMPHYSEMA | 140 | ||
| PREDOMINANCE OF CHRONIC BRONCHITIS | 141 | ||
| PATHOLOGY | 141 | ||
| EMPHYSEMA | 142 | ||
| PATHOBIOLOGY | 143 | ||
| α1-ANTITRYPSIN | 144 | ||
| PATHOPHYSIOLOGY | 144 | ||
| RADIOGRAPHIC APPEARANCE | 146 | ||
| MANAGEMENT | 147 | ||
| PREVENTIVE MEASURES | 147 | ||
| TREATMENT OF STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 149 | ||
| TREATMENT OF EXACERBATIONS | 150 | ||
| TREATMENT COMPLICATIONS | 151 | ||
| SURGICAL TREATMENT | 152 | ||
| BRONCHIECTASIS | 153 | ||
| CAUSE | 153 | ||
| DIAGNOSIS | 153 | ||
| CLINICAL COURSE | 154 | ||
| MANAGEMENT | 154 | ||
| CYSTIC FIBROSIS | 155 | ||
| GENETICS | 155 | ||
| DIAGNOSIS | 155 | ||
| CLINICAL MANIFESTATIONS | 155 | ||
| PULMONARY DISEASE | 156 | ||
| GASTROINTESTINAL DISEASE | 156 | ||
| ENDOCRINE DISEASE | 157 | ||
| FERTILITY | 157 | ||
| PROGNOSIS | 157 | ||
| LUNG CANCER OVERVIEW | 158 | ||
| LUNG CANCER STAGING | 159 | ||
| SQUAMOUS CELL CARCINOMA OF THE LUNG | 160 | ||
| ADENOCARCINOMA OF THE LUNG | 161 | ||
| LARGE CELL CARCINOMAS OF THE LUNG | 162 | ||
| SMALL CELL CARCINOMAS OF THE LUNG | 163 | ||
| SUPERIOR VENA CAVA SYNDROME | 164 | ||
| PANCOAST TUMOR AND SYNDROME | 165 | ||
| PARANEOPLASTIC MANIFESTATIONS OF LUNG CANCER | 166 | ||
| OTHER NEOPLASMS OF THE LUNG | 168 | ||
| BENIGN TUMORS OF THE LUNG | 169 | ||
| MALIGNANT PLEURAL MESOTHELIOMA | 170 | ||
| MEDIASTINAL TUMORS: ANTERIOR MEDIASTINUM | 171 | ||
| MIDDLE-POSTERIOR AND PARAVERTEBRAL MEDIASTINUM | 172 | ||
| PULMONARY METASTASES | 173 | ||
| OVERVIEW OF PNEUMONIA | 174 | ||
| PNEUMOCOCCAL PNEUMONIA | 175 | ||
| CAUSE | 175 | ||
| PATHOGENESIS AND PATHOLOGY | 175 | ||
| CLINICAL FEATURES | 175 | ||
| THERAPY | 176 | ||
| PREVENTION | 176 | ||
| ATYPICAL PATHOGEN PNEUMONIA | 177 | ||
| ATYPICAL PATHOGENS | 177 | ||
| MYCOPLASMA PNEUMONIA | 177 | ||
| CHLAMYDOPHILA INFECTIONS | 178 | ||
| LEGIONELLA PNEUMOPHILA | 178 | ||
| STAPHYLOCOCCUS AUREUS PNEUMONIA | 180 | ||
| EPIDEMIOLOGY | 180 | ||
| CLINICAL FEATURES | 180 | ||
| TREATMENT | 180 | ||
| HAEMOPHILUS INFLUENZAE PNEUMONIA | 181 | ||
| GRAM–NEGATIVE BACTERIAL PNEUMONIA | 182 | ||
| VIRAL COMMUNITY-ACQUIRED PNEUMONIA | 183 | ||
| ETIOLOGIC VIRAL PATHOGENS | 183 | ||
| CLINICAL MANIFESTATIONS | 185 | ||
| DIAGNOSIS | 186 | ||
| THERAPY | 187 | ||
| PREVENTION | 187 | ||
| LUNG ABSCESS | 188 | ||
| PATHOGENESIS | 188 | ||
| CLINICAL FEATURES | 189 | ||
| DIAGNOSTIC TESTING | 189 | ||
| THERAPY | 189 | ||
| OVERVIEW OF HEALTH CARE–ASSOCIATED PNEUMONIA, HOSPITAL-ACQUIRED PNEUMONIA, AND VENTILATOR ASSOCIATED PNEUMONIA | 190 | ||
| HEALTH CARE–ASSOCIATED PNEUMONIA DEFINITIONS AND EPIDEMIOLOGY | 190 | ||
| HOSPITAL-ACQUIRED PNEUMONIA AND VENTILATOR-ASSOCIATED PNEUMONIA DEFINITIONS AND EPIDEMIOLOGY | 190 | ||
| CAUSE AND DIAGNOSTIC TESTING | 190 | ||
| ANTIBIOTIC RESISTANCE | 191 | ||
| MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS | 191 | ||
| METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS | 191 | ||
| PNEUMONIA IN THE COMPROMISED HOST | 192 | ||
| PNEUMONIA WITH HIV INFECTION | 193 | ||
| ACTINOMYCOSIS | 194 | ||
| TREATMENT | 194 | ||
| NOCARDIOSIS | 195 | ||
| TREATMENT | 195 | ||
| HISTOPLASMOSIS | 196 | ||
| TREATMENT | 197 | ||
| COCCIDIOIDOMYCOSIS | 198 | ||
| TREATMENT | 198 | ||
| BLASTOMYCOSIS | 199 | ||
| TREATMENT | 199 | ||
| PARACOCCIDIOIDOMYCOSIS | 200 | ||
| TREATMENT | 200 | ||
| CRYPTOCOCCOSIS | 201 | ||
| TREATMENT | 201 | ||
| ASPERGILLOSIS | 202 | ||
| ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | 202 | ||
| ASPERGILLOMA | 202 | ||
| INVASIVE ASPERGILLOSIS | 202 | ||
| TUBERCULOSIS | 203 | ||
| BACKGROUND | 203 | ||
| TRANSMISSION AND PATHOGENESIS | 204 | ||
| TUBERCULIN SKIN TESTING AND INTERFERON-γ RELEASE ASSAYS | 205 | ||
| CHEST RADIOGRAPHY | 206 | ||
| SPUTUM STUDIES | 206 | ||
| TREATMENT OF TUBERCULOSIS | 208 | ||
| PREVENTING NOSOCOMIAL TRANSMISSION OF TUBERCULOSIS | 211 | ||
| NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE | 212 | ||
| EPIDEMIOLOGY | 212 | ||
| NONTUBERCULOUS MYCOBACTERIAL SPECIES | 212 | ||
| DIAGNOSTIC CRITERIA | 212 | ||
| TREATMENT | 212 | ||
| OVERVIEW OF INHALATION DISEASES | 213 | ||
| SILICOSIS | 214 | ||
| PATHOLOGY | 214 | ||
| CLINICAL FEATURES | 214 | ||
| WORKPLACE EXPOSURE | 215 | ||
| SILICOTUBERCULOSIS | 215 | ||
| CAPLAN NODULES | 215 | ||
| COAL WORKER’S PNEUMOCONIOSIS | 216 | ||
| ASBESTOSIS AND ASBESTOS-RELATED DISEASES | 217 | ||
| ASBESTOSIS | 217 | ||
| BENIGN ASBESTOS-RELATED PLEURAL DISEASE | 218 | ||
| ASBESTOS-RELATED MALIGNANCY | 218 | ||
| BERYLLIUM | 219 | ||
| CHRONIC BERYLLIUM DISEASE | 219 | ||
| PATHOGENESIS | 219 | ||
| DIAGNOSIS | 219 | ||
| THERAPY | 219 | ||
| PNEUMOCONIOSIS CAUSED BY VARIOUS MINERALS AND MIXED DUSTS | 220 | ||
| KAOLIN | 220 | ||
| MIXED-DUST PNEUMOCONIOSIS | 220 | ||
| COBALT PNEUMOCONIOSIS (HARD METAL DISEASE) | 220 | ||
| CADMIUM | 221 | ||
| FULLER EARTH | 221 | ||
| GRAPHITE | 221 | ||
| SIDEROSIS | 221 | ||
| HYPERSENSITIVITY PNEUMONITIS | 222 | ||
| PULMONARY EMBOLISM AND VENOUS THROMBOEMBOLISM | 224 | ||
| RISK FACTORS FOR PULMONARY EMBOLISM | 224 | ||
| PATHOPHYSIOLOGY | 224 | ||
| CLINICAL MANIFESTATIONS OF LEG VEIN THROMBOSIS | 224 | ||
| DIAGNOSIS OF DEEP VENOUS THROMBOSIS | 226 | ||
| CLINICAL MANIFESTATIONS OF PULMONARY EMBOLISM | 226 | ||
| DIAGNOSIS OF PULMONARY EMBOLISM | 227 | ||
| PROPHYLAXIS AND TREATMENT | 229 | ||
| CHRONIC EFFECTS OF PULMONARY EMBOLISM | 230 | ||
| SPECIAL SITUATIONS AND EXTRAVASCULAR SOURCES OF PULMONARY EMBOLI | 232 | ||
| MALIGNANCY | 232 | ||
| PREGNANCY | 232 | ||
| FAT EMBOLISM | 232 | ||
| AMNIOTIC FLUID EMBOLISM | 232 | ||
| AIR EMBOLISM | 232 | ||
| FOREIGN BODY EMBOLISM | 232 | ||
| PULMONARY HYPERTENSION | 233 | ||
| CLASSIFICATION | 233 | ||
| PATHOPHYSIOLOGY OF PULMONARY ARTERIAL HYPERTENSION | 233 | ||
| DIAGNOSIS | 233 | ||
| TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | 234 | ||
| INTERVENTIONAL AND SURGICAL THERAPIES | 236 | ||
| PULMONARY EDEMA | 237 | ||
| NORMAL PHYSIOLOGY | 237 | ||
| CARDIOGENIC PULMONARY EDEMA | 237 | ||
| NONCARDIOGENIC PULMONARY EDEMA | 237 | ||
| SPECIFIC CLINICAL CAUSES OF NONCARDIOGENIC PULMONARY EDEMA | 238 | ||
| EVALUATION OF PATIENTS WITH PULMONARY EDEMA | 238 | ||
| PATHOPHYSIOLOGY OF PLEURAL FLUID ACCUMULATION | 239 | ||
| PLEURAL EFFUSION IN HEART DISEASE | 240 | ||
| UNEXPANDABLE LUNG | 241 | ||
| PARAPNEUMONIC EFFUSION | 242 | ||
| PLEURAL EFFUSION IN MALIGNANCY | 243 | ||
| CHYLOTHORAX | 244 | ||
| RIB AND STERNAL FRACTURES | 245 | ||
| FLAIL CHEST AND PULMONARY CONTUSION | 246 | ||
| PNEUMOTHORAX | 247 | ||
| HEMOTHORAX | 249 | ||
| PULMONARY LACERATION | 250 | ||
| TRACHEOBRONCHIAL RUPTURE | 251 | ||
| TRAUMATIC ASPHYXIA | 252 | ||
| DIAPHRAGMATIC INJURIES | 253 | ||
| RESPIRATORY DISTRESS SYNDROME | 254 | ||
| EPIDEMIOLOGY | 254 | ||
| PATHOLOGY | 254 | ||
| PATHOGENESIS | 254 | ||
| DIAGNOSIS | 254 | ||
| RADIOLOGIC FINDINGS | 255 | ||
| TREATMENT | 255 | ||
| COMPLICATIONS OF RESPIRATORY THERAPY | 255 | ||
| PROGNOSIS | 255 | ||
| ACUTE LUNG INJURY | 256 | ||
| EPIDEMIOLOGY | 256 | ||
| PATHOGENESIS | 256 | ||
| TREATMENT | 256 | ||
| OUTCOMES | 256 | ||
| IDIOPATHIC INTERSTITIAL PNEUMONIAS | 257 | ||
| IDIOPATHIC PULMONARY FIBROSIS | 257 | ||
| NONSPECIFIC INTERSTITIAL PNEUMONIA | 257 | ||
| RESPIRATORY BRONCHIOLITIS–ASSOCIATED INTERSTITIAL LUNG DISEASES | 258 | ||
| LYMPHOID INTERSTITIAL PNEUMONITIS | 258 | ||
| ACUTE INTERSTITIAL PNEUMONIA | 259 | ||
| DESQUAMATIVE INTERSTITIAL PNEUMONIA | 259 | ||
| CRYPTOGENIC ORGANIZING PNEUMONIA | 260 | ||
| PULMONARY ALVEOLAR PROTEINOSIS | 261 | ||
| IDIOPATHIC PULMONARY HEMOSIDEROSIS | 262 | ||
| LYMPHANGIOLEIOMYOMATOSIS | 263 | ||
| TUBEROUS SCLEROSIS | 263 | ||
| PULMONARY LANGERHANS CELL HISTIOCYTOSIS | 264 | ||
| SARCOIDOSIS | 265 | ||
| RHEUMATOID ARTHRITIS | 267 | ||
| SYSTEMIC SCLEROSIS (SCLERODERMA) | 268 | ||
| SYSTEMIC LUPUS ERYTHEMATOSUS | 269 | ||
| DERMATOMYOSITIS AND POLYMYOSITIS | 270 | ||
| PULMONARY VASCULITIS | 271 | ||
| EOSINOPHILIC PNEUMONIA | 272 | ||
| PULMONARY MANIFESTATIONS OF OTHER DISEASES | 273 | ||
| PULMONARY MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE | 273 | ||
| PULMONARY MANIFESTATIONS OF LIVER DISEASE: HEPATOPULMONARY SYNDROME | 273 | ||
| PULMONARY COMPLICATIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: BRONCHIOLITIS OBLITERANS AND IDIOPATHIC PNEUMONIA SYNDROME | 274 | ||
| SLEEP MEDICINE | 275 | ||
| SLEEP-DISORDERED BREATHING | 276 | ||
| SECTION 5: THERAPIES AND THERAPEUTIC PROCEDURES | 277 | ||
| PULMONARY PHARMACOLOGY | 278 | ||
| β2-ADRENERGIC AGONISTS | 278 | ||
| THEOPHYLLINE (METHYLXANTHINES) | 279 | ||
| ANTICHOLINERGICS | 281 | ||
| CORTICOSTEROIDS | 281 | ||
| CROMONES | 283 | ||
| ANTILEUKOTRIENES | 284 | ||
| ANTI-IgE THERAPY | 285 | ||
| IMMUNOSUPPRESSIVE AND CORTICOSTEROID-SPARING THERAPY | 286 | ||
| ANTITUSSIVES | 286 | ||
| DRUGS FOR DYSPNEA | 287 | ||
| VENTILATORY STIMULANTS | 287 | ||
| PULMONARY REHABILITATION | 288 | ||
| OXYGEN THERAPY IN ACUTE RESPIRATORY FAILURE | 289 | ||
| ARTERIAL BLOOD GAS COMPOSITION | 289 | ||
| CARE AND MONITORING DURING OXYGEN THERAPY | 289 | ||
| METHODS OF OXYGEN ADMINISTRATION | 290 | ||
| OXYGEN THERAPY IN CHRONIC RESPIRATORY FAILURE (AMBULATORY AND HOME USE) | 291 | ||
| INTRODUCTION OF CHEST DRAINAGE TUBES | 292 | ||
| CHEST-DRAINING METHODS | 293 | ||
| POSTURAL DRAINAGE AND BREATHING EXERCISES | 294 | ||
| UPPER AIRWAY OBSTRUCTION AND THE HEIMLICH MANEUVER | 295 | ||
| SECURING AN EMERGENT AIRWAY | 296 | ||
| ENDOTRACHEAL INTUBATION | 297 | ||
| TRACHEOSTOMY | 298 | ||
| MORBIDITY OF ENDOTRACHEAL INTUBATION AND TRACHEOSTOMY | 299 | ||
| ENDOTRACHEAL SUCTION | 300 | ||
| MECHANICAL VENTILATION | 301 | ||
| INDICATIONS AND GOALS OF THERAPY | 301 | ||
| PRINCIPLES OF POSITIVE-PRESSURE MECHANICAL VENTILATION | 301 | ||
| TRACHEAL RESECTION AND ANASTOMOSIS | 302 | ||
| REMOVAL OF MEDIASTINAL TUMORS | 303 | ||
| SUBLOBAR RESECTION AND SURGICAL LUNG BIOPSY | 304 | ||
| SEGMENTAL RESECTION | 304 | ||
| WEDGE RESECTION | 304 | ||
| LOBECTOMY | 305 | ||
| PNEUMONECTOMY | 306 | ||
| VIDEO-ASSISTED THORACOSCOPIC SURGERY | 308 | ||
| LUNG VOLUME REDUCTION SURGERY | 309 | ||
| LUNG TRANSPLANTATION | 310 | ||
| SELECTED REFERENCES | 311 | ||
| Section 1: Anatomy and Embryology | 311 | ||
| Section 2: Physiology | 311 | ||
| Section 3: Diagnostic Procedures | 311 | ||
| Section 4: Diseases and Pathology | 312 | ||
| Section 5: Therapies and Therapeutic Procedures | 314 | ||
| INDEX | 317 |